| scholarly article | Q13442814 |
| P2093 | author name string | Jing Liu | |
| Li Xie | |||
| Zhi-Hong Liu | |||
| Yuan-Yuan Liu | |||
| Jin-Lin Hou | |||
| Ji-Dong Jia | |||
| Fu-Qiang Cui | |||
| Gui-Hua Zhuang | |||
| Li-Bo Tao | |||
| Xue-Ru Yin | |||
| P2860 | cites work | Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis | Q36129521 |
| Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression | Q36157148 | ||
| Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis | Q37121872 | ||
| Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. | Q37462557 | ||
| WHO Guide for standardisation of economic evaluations of immunization programmes | Q37536433 | ||
| EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection | Q38692559 | ||
| Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs). | Q39067311 | ||
| Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China | Q39121074 | ||
| Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study | Q40654262 | ||
| Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection | Q40934257 | ||
| Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B. | Q40958942 | ||
| The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis | Q41684446 | ||
| Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study | Q41968114 | ||
| A randomized, open-label clinical study of combined pegylated interferon Alfa-2a (40KD) and entecavir treatment for hepatitis B "e" antigen-positive chronic hepatitis B. | Q42192860 | ||
| Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial). | Q42213262 | ||
| HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability | Q42259579 | ||
| Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome | Q42439836 | ||
| Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. | Q42678962 | ||
| Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). | Q47142488 | ||
| Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China | Q47320418 | ||
| Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance | Q50190669 | ||
| Combination Therapy With Tenofovir and Peginterferon May Not Be Translated Into Current Clinical Practice. | Q50272341 | ||
| HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study. | Q52632456 | ||
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study | Q56830540 | ||
| [Study on the natural history of chronic hepatitis B] | Q77665068 | ||
| P433 | issue | 19 | |
| P921 | main subject | chronic hepatitis B | Q55779876 |
| P304 | page(s) | 2315-2324 | |
| P577 | publication date | 2019-10-01 | |
| P1433 | published in | Chinese Medical Journal | Q5100534 |
| P1476 | title | First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China | |
| P478 | volume | 132 |
| Q99411164 | Management of chronic liver diseases and cirrhosis: current status and future directions | cites work | P2860 |
Search more.